Literature DB >> 32381590

Ethics of controlled human infection to address COVID-19.

Seema K Shah1, Franklin G Miller2, Thomas C Darton2, Devan Duenas2, Claudia Emerson2, Holly Fernandez Lynch2, Euzebiusz Jamrozik2, Nancy S Jecker2, Dorcas Kamuya2, Melissa Kapulu2, Jonathan Kimmelman2, Douglas MacKay2, Matthew J Memoli2, Sean C Murphy2, Ricardo Palacios2, Thomas L Richie2, Meta Roestenberg2, Abha Saxena2, Katherine Saylor2, Michael J Selgelid2, Vina Vaswani2, Annette Rid2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32381590     DOI： 10.1126/science.abc1076

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  27 in total

1.  Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.

Authors:  Jeffrey P Kahn; Leslie Meltzer Henry; Anna C Mastroianni; Wilbur H Chen; Ruth Macklin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-29       Impact factor: 11.205

2.  Research ethics and public trust in vaccines: the case of COVID-19 challenge trials.

Authors:  Nir Eyal
Journal:  J Med Ethics       Date:  2022-05-20       Impact factor: 5.926

3.  COVID-19: Advancing Empirical Bioethics Research.

Authors:  Connie M Ulrich; Emily E Anderson; Jennifer K Walter
Journal:  AJOB Empir Bioeth       Date:  2020-07-13

4.  Standards of evidence for institutional review board decision-making.

Authors:  David B Resnik
Journal:  Account Res       Date:  2020-12-08       Impact factor: 3.057

5.  Human Infection Challenge Studies: a Test for the Social Value Criterion of Research Ethics.

Authors:  Nicholas G Evans
Journal:  mSphere       Date:  2020-07-15       Impact factor: 4.389

6.  AIDS Activism and Coronavirus Vaccine Challenge Trials.

Authors:  Nir Eyal; Perry N Halkitis
Journal:  AIDS Behav       Date:  2020-12

Review 7.  So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development.

Authors:  Christine Grady; Seema Shah; Franklin Miller; Marion Danis; Marie Nicolini; Jorge Ochoa; Holly Taylor; Dave Wendler; Annette Rid
Journal:  Vaccine       Date:  2020-08-11       Impact factor: 3.641

8.  Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines.

Authors:  Robert Steel; Lara Buchak; Nir Eyal
Journal:  J Med Ethics       Date:  2020-07-13       Impact factor: 2.903

9.  Participating in a vaccine trial for COVID-19 in Senegal: trust and information.

Authors:  V Ridde; M F Ba; I Gaye; A I Diallo; E Bonnet; A Faye
Journal:  Hum Vaccin Immunother       Date:  2021-07-19       Impact factor: 4.526

10.  COVID-19 vaccine development: Time to consider SARS-CoV-2 challenge studies?

Authors:  G Owen Schaefer; Clarence C Tam; Julian Savulescu; Teck Chuan Voo
Journal:  Vaccine       Date:  2020-06-04       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.